Clinical Trial Update: Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing cyclophosphamide with methylprednisolone in secondary progressive multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Secondary Progressive

Drugs mentioned

• Cytoxan (cyclophosphamide)
• SOLU-MEDROL (Methylprednisolone sodium succinate)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Multiple Sclerosis, Chronic Progressive | Phase 3 | Status: COMPLETED